Tarceva (OSI-774)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tarceva (OSI-774), covering 2013-09-30 to 2013-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer [Phase 1]